Brian Winter

Managing Director and Senior Equity Analyst at Zacks Investment Management

Brian Winter is a Managing Director and Senior Equity Analyst at Zacks Small-Cap Research, focusing on in-depth coverage of emerging and micro-cap companies across healthcare, technology, and industrials. He has provided detailed research and analysis on specific firms such as VolitionRx, BioLargo, and Myomo, gaining recognition for uncovering undervalued investment opportunities and delivering actionable insights to investors. With a career beginning in institutional equity research in the early 2000s, Brian joined Zacks Small-Cap Research in the mid-2010s after previous roles at regional investment firms, and he has earned a reputation for high-quality, data-driven recommendations. He holds FINRA Series 7, 63, and 86/87 licenses, cementing his status as a credentialed securities analyst trusted by both retail and institutional clients.

Brian Winter's questions to Core AI Holdings (SYTA) leadership

Question · Q3 2023

Nov 16, 2023

Inquired about the key market verticals for the Real Time View product, the sales strategy for it, the company's future financing needs, and the current number of outstanding shares.

Answer

The executive identified EMS, commercial fleets, and security fleets as key verticals for the Real Time View product, which will be sold by the existing sales team. He acknowledged the need to raise an additional $2-3 million to support growth and reach profitability. The outstanding share count is approximately 4.2 million.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies

Access millions of SEC filings & transcripts

Get answers cited to the source

Try Fintool for Free

Trusted by leading investment firms and analysts